Publications 2024

Podgorica M, Drivet E, Viken JK, Richman A, Vestbøstad J, Szodoray P, Kvam AK, Wik HS, Tjønnfjord GE, Munthe LA, Frietze S, Schjerven H (2024)
Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis
Eur J Haematol, 112 (5), 731-742
DOI 10.1111/ejh.14164, PubMed 38192186

Publications 2021

Kvam AK, Torp HA, Iversen PO (2021)
Life-Threatening Acute Chest Syndrome in a Patient With Sickle Cell Disease After Switching From Hydroxyurea Therapy to Partial Exchange Transfusions: A Case Report
Cureus, 13 (12), e20236
DOI 10.7759/cureus.20236, PubMed 35004051

Tjonnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
Monoclonal gammopathy of clinical importance
Tidsskr. Nor. Laegeforen., 141 (13), 1276-1280

Tjønnfjord GE, Schjesvold FH, Gulbrandsen N, Kvam AK (2021)
[Monoclonal gammopathy of clinical importance]
Tidsskr Nor Laegeforen, 141 (2021-13)
DOI 10.4045/tidsskr.20.0981, PubMed 34596996

Publications 2020

Hagestande S, Kvam AK, Lothe IMB, Gjelberg HK, Bruserud O, Tvedt THA (2020)
Aplastic anaemia
Tidsskr. Nor. Laegeforen., 140 (18), 1897-1900

Hagestande S, Kvam AK, Lothe IMB, Gjelberg HK, Bruserud Ø, Tvedt THA (2020)
[Aplastic anaemia]
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0139, PubMed 33322881

Publications 2016

Barratt-Due A, Fløisand Y, Orrem HL, Kvam AK, Holme PA, Bergseth G, Tjønnfjord GE, Mollnes TE (2016)
Complement activation is a crucial pathogenic factor in catastrophic antiphospholipid syndrome
Rheumatology (Oxford), 55 (7), 1337-9
DOI 10.1093/rheumatology/kew040, PubMed 27105662

Publications 2015

Kvam AK, Waage A (2015)
Health-related quality of life in patients with multiple myeloma--does it matter?
Haematologica, 100 (6), 704-5
DOI 10.3324/haematol.2015.127860, PubMed 26034111

Publications 2013

Enden T, Wik HS, Kvam AK, Haig Y, Kløw NE, Sandset PM (2013)
Health-related quality of life after catheter-directed thrombolysis for deep vein thrombosis: secondary outcomes of the randomised, non-blinded, parallel-group CaVenT study
BMJ Open, 3 (8), e002984
DOI 10.1136/bmjopen-2013-002984, PubMed 23988361

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-54
DOI 10.1182/blood-2012-11-464503, PubMed 23616624

Publications 2011

Kvam AK, Fayers PM, Wisloff F (2011)
Responsiveness and minimal important score differences in quality-of-life questionnaires: a comparison of the EORTC QLQ-C30 cancer-specific questionnaire to the generic utility questionnaires EQ-5D and 15D in patients with multiple myeloma
Eur J Haematol, 87 (4), 330-7
DOI 10.1111/j.1600-0609.2011.01665.x, PubMed 21668504

Publications 2010

Kvam AK, Wisløff F, Fayers PM (2010)
Minimal important differences and response shift in health-related quality of life; a longitudinal study in patients with multiple myeloma
Health Qual Life Outcomes, 8, 79
DOI 10.1186/1477-7525-8-79, PubMed 20678240

Publications 2009

Kvam AK, Fayers P, Hjermstad M, Gulbrandsen N, Wisloff F (2009)
Health-related quality of life assessment in randomised controlled trials in multiple myeloma: a critical review of methodology and impact on treatment recommendations
Eur J Haematol, 83 (4), 279-89
DOI 10.1111/j.1600-0609.2009.01303.x, PubMed 19558508

Kvam AK, Fayers P, Wisloff F (2009)
What changes in health-related quality of life matter to multiple myeloma patients? A prospective study
Eur J Haematol, 84 (4), 345-53
DOI 10.1111/j.1600-0609.2009.01404.x, PubMed 20041946

Publications 2006

Wisløff F, Kvam AK, Hjorth M, Lenhoff S (2006)
Serum calcium is an independent predictor of quality of life in multiple myeloma
Eur J Haematol, 78 (1), 29-34
DOI 10.1111/j.0902-4441.2006.t01-1-EJH2887.x, PubMed 17038019